Literature DB >> 717389

Corticosteroid-induced lymphocytopenia in man: absence of splenic influence and effect of recipient serum.

G P Beardsley, H J Cohen.   

Abstract

Pharmacologic doses of corticosteroids produce a profound, transient lymphocytopenia in man. We have studied the role of the spleen and possible induction of cytolytic factors in the generation of this effect. A 200 mg IV dose of hydrocortisone-21-hemisuccinate was administered to five normal subjects and five subjects whose spleens had been removed as a result of trauma. Sequential peripheral blood lymphocyte counts and subpopulations were then determined, and the effect of serum (obtained from the recipients at several time points after steroid administration) on autologous lymphocyte viability was assessed in vitro. The asplenic subjects experienced the same marked lymphocytopenia as normal individuals, and post-steroid serum was not cytotoxic to autologous lymphocytes. The in vitro results support the view that corticosteroid-induced lymphocytopenia is not the result of lymphocytolysis in man. If lymphocyte redistribution is the cause, as has been suggested, our in vivo results directly demonstrate that the spleen does not play a major role.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 717389     DOI: 10.1002/ajh.2830040307

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  3 in total

1.  Corticosteroid effects on circulating lymphocyte subset levels in normal humans.

Authors:  B Zweiman; P C Atkins; P M Bedard; S L Flaschen; R P Lisak
Journal:  J Clin Immunol       Date:  1984-03       Impact factor: 8.317

2.  Myeloid leukaemia following therapy for a first primary cancer.

Authors:  A Nandakumar; S Davis; S Moolgavkar; R P Witherspoon; S M Schwartz
Journal:  Br J Cancer       Date:  1991-05       Impact factor: 7.640

3.  Immunosuppression with glucocorticoids--a possible immunological explanation for interpatient variation in sensitivity: discussion paper.

Authors:  J S Beck; M C Browning
Journal:  J R Soc Med       Date:  1983-06       Impact factor: 18.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.